MILD TO MODERATE HYPERTENSION
Clinical trials for MILD TO MODERATE HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new MILD TO MODERATE HYPERTENSION trials appear
Sign up with your email to follow new studies for MILD TO MODERATE HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot aims to lower blood pressure for months
Disease control Recruiting nowThis study tests a single dose of an experimental drug called ALN-AGT01 in adults with mild to moderate high blood pressure who have already been treated with another drug, zilebesiran. The goal is to see if it safely helps control blood pressure by measuring changes in blood pre…
Matched conditions: MILD TO MODERATE HYPERTENSION
Phase: PHASE2 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New shot could tame high blood pressure – early trial underway
Disease control Recruiting nowThis Phase 2 trial tests an injectable drug called HRS-9563 in 234 adults with mild to moderate hypertension. Participants are randomly assigned to receive either the drug or a placebo injection. The main goal is to see if HRS-9563 can safely lower average blood pressure over 24 …
Matched conditions: MILD TO MODERATE HYPERTENSION
Phase: PHASE2 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC